Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial - Heerspink, HJL; Sattar, N; Pavo, I (Lancet Diabetes Endocrinol, 2022)